Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Urinary Bladder Neoplasms × pazopanib × 30 days × Clear all

Sponsor

Conditions

Sarcoma 3 Carcinoma, Renal Cell 3 Solid Neoplasm 1 Sarcoma, Synovial 1 Sarcoma, Clear Cell 1 Sarcoma, Alveolar Soft Part 1 Perivascular Epithelioid Cell Neoplasms 1 Neurofibrosarcoma 1 Neuroendocrine Tumors 1 Nerve Sheath Neoplasms 1 Liposarcoma 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Histiocytoma, Angiomatoid Fibrous 1 Granuloma, Plasma Cell 1 Fibrosarcoma 1 Dermatofibrosarcoma 1 Chondrosarcoma, Mesenchymal 1 Chondrosarcoma, Extraskeletal Myxoid 1

Interventions

Gemcitabine 15 Specimen Handling 13 Magnetic Resonance Spectroscopy 12 pembrolizumab 9 Cisplatin 9 durvalumab 6 Cystoscopy 6 Nivolumab 5 Docetaxel 5 atezolizumab 4 Transurethral Resection of Bladder 4 Radiotherapy 4 Radiation 4 Paclitaxel 4 Mitomycin 4 Carboplatin 4 Biopsy 4 erdafitinib 3 enfortumab vedotin 3 cabozantinib 3 avelumab 3 Standard of Care 3 Ipilimumab 3 Immunoglobulin G 3 Fluorouracil 3 Disulfides 3 CTLA-4 Antigen 3 sacituzumab govitecan 2 eribulin 2 dehydroftorafur 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡